A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperact...

por Savill, Nicola, Bushe, Chris J
Publicado 2012

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians

por Bushe, Chris J., Savill, Nicola
Publicado 2011

Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical t...

por Bushe, Chris J, Savill, Nicola C
Publicado 2013

Intramuscular Olanzapine – a UK case series of early cases

por Bushe, Chris J, Taylor, Mark, Mathew, Mathew
Publicado 2007

Mortality in schizophrenia: a measurable clinical endpoint

por Bushe, Chris J, Taylor, Mark, Haukka, Jari
Publicado 2010

Cancer and schizophrenia: is there a paradox?

por Hodgson, Richard, Wildgust, Hiram J, Bushe, Chris J
Publicado 2010

Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation

por Bushe, Chris J, McNamara, Dermot, Haley, Cliff, McCrossan, Mary Fleming, Devitt, Pat
Publicado 2008

Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice

por Bushe, Chris J, Falk, Deborah, Anand, Ernie, Casillas, Marta, Perrin, Elena, Chhabra-Khanna, Rashna, Detke, Holland C
Publicado 2015